AI Article Synopsis
- Scientists are studying how certain genes can change normal cells into cancer cells, which can grow out of control and resist treatment.
- They focused on a specific pathway called the BAD-mediated apoptotic pathway to see how it relates to different types of cancer like ovarian, breast, and colon cancer.
- Their research found higher levels of a protein called pBAD in cancer cells compared to normal cells, suggesting that this pathway helps cancer cells grow and survive better.
Article Abstract
The malignant transformation of normal cells is caused in part by aberrant gene expression disrupting the regulation of cell proliferation, apoptosis, senescence and DNA repair. Evidence suggests that the Bcl-2 antagonist of cell death (BAD)-mediated apoptotic pathway influences cancer chemoresistance. In the present study, we explored the role of the BAD-mediated apoptotic pathway in the development and progression of cancer. Using principal component analysis to derive a numeric score representing pathway expression, we evaluated clinico-genomic datasets (n=427) from corresponding normal, pre-invasive and invasive cancers of different types, such as ovarian, endometrial, breast and colon cancers in order to determine the associations between the BAD-mediated apoptotic pathway and cancer development. Immunofluorescence was used to compare the expression levels of phosphorylated BAD [pBAD (serine-112, -136 and -155)] in immortalized normal and invasive ovarian, colon and breast cancer cells. The expression of the BAD-mediated apoptotic pathway phosphatase, PP2C, was evaluated by RT-qPCR in the normal and ovarian cancer tissue samples. The growth-promoting effects of pBAD protein levels in the immortalized normal and cancer cells were assessed using siRNA depletion experiments with MTS assays. The expression of the BAD-mediated apoptotic pathway was associated with the development and/or progression of ovarian (n=106, p<0.001), breast (n=185, p<0.0008; n=61, p=0.04), colon (n=22, p<0.001) and endometrial (n=33, p<0.001) cancers, as well as with ovarian endometriosis (n=20, p<0.001). Higher pBAD protein levels were observed in the cancer cells compared to the immortalized normal cells, whereas PP2C gene expression was lower in the cancer compared to the ovarian tumor tissue samples (n=76, p<0.001). The increased pBAD protein levels after the depletion of PP2C conferred a growth advantage to the immortalized normal and cancer cells. The BAD-mediated apoptotic pathway is thus associated with the development of human cancers likely influenced by the protein levels of pBAD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356438 | PMC |
| http://dx.doi.org/10.3892/ijmm.2015.2091 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer.
Transl Oncol
November 2024
Precision Medicine and Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute, Tsinghua University, Shenzhen 518055, Guangdong, PR China; Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, PR China. Electronic address:
Objective: Mitomycin C (MMC), a DNA-damaging chemotherapeutic, is commonly used clinically for recurrent cervical carcinoma (CC), either alone or in combination. MMC generates DNA damage resulting in CC cell death yet also induces increased AKT-BAD phosphorylation associated with drug resistance and reduced clinical benefit. The present study evaluates the efficacy of combined MMC and a BAD phosphorylation inhibitor in CC.
View Article and Find Full Text PDFBAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology.
iScience
September 2021
Institute of Modern Biology, Nanjing University, Nanjing 210023, China.
Article Synopsis
- Alzheimer's disease (AD) is a common neurodegenerative disease, but the exact biological processes behind it are not fully understood.
- The pro-apoptotic protein BAD is identified as a crucial factor in increasing neuron death, triggering neuroinflammation, and reducing the clearance of amyloid-beta (Aβ) in AD.
- Disrupting BAD's activity in mice with AD improves learning and memory, indicating that targeting BAD could be a promising therapeutic approach for treating the disease.
The heart of a hibernator: EGFR and MAPK signaling in cardiac muscle during the hibernation of thirteen-lined ground squirrels, .
PeerJ
September 2019
Institute of Biochemistry, Department of Biology and Chemistry, Carleton University, Ottawa, ON, Canada.
Article Synopsis
- - The study investigates how the epidermal growth factor receptor (EGFR) and related signaling pathways function in thirteen-lined ground squirrels during winter hibernation, focusing on physiological and molecular changes that occur when their heart experiences reduced blood circulation.
- - Researchers measured protein levels related to EGFR phosphorylation, MAPK pathways, and apoptosis in cardiac muscle at different points during hibernation and found specific increases and decreases in these proteins, especially during the arousal phase from torpor.
- - Key findings showed that EGFR phosphorylation and MAPK activity were significantly altered during the hibernation cycle, indicating complex regulatory mechanisms, with notable apoptosis and heat shock protein changes suggesting adaptive cardiac responses to extreme environmental conditions.
Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
J Virol
February 2016
Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Unlabelled: Epstein-Barr virus (EBV) is a human gammaherpesvirus associated with a variety of tumor types. EBV can establish latency or undergo lytic replication in host cells. In general, EBV remains latent in tumors and expresses a limited repertoire of latent proteins to avoid host immune surveillance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!